Instituto di Biomedicina ed immunologia molecolare Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2015
NCT02729012
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

IBIM,CNR, PALERMO, ITALY

Active Ingredients

Drugs in Phase 4 Trials (1)

sodium chloride (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Inflammation (Phase 4)

Rhinitis (Phase 4)

Rhinitis, Allergic (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1